2nd Covalent Drug Discovery Summit
The covalent drug discovery field is pushing boundaries in oncology, immunology, and CNS by tackling challenging protein targets using innovative covalent modalities and novel warheads that go beyond cysteine targeting. Despite significant progress, the development of covalent drugs is complex, with ongoing challenges in optimizing reactivity and selectivity, improving ligandability of alternative amino acids, and addressing PKPD and efficiency issues. The 2nd Covalent Drug Discovery & Development Summit brings together experts from proteomics, chemical biology, biochemistry, and pharmacology to explore these challenges and share insights, helping to expand the scope of the druggable proteome.
Resource Links
WuXi AppTec Discovery Services
Resource Type: Brochure
